LUMEVOI

lenadogene nolparvovec · GenSight Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LUMEVOI, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients [Phase 1, Phase 2]